25 XP   0   0   10

Shanghai Pharmaceuticals Holding Co Ltd
Buy, Hold or Sell?

Let's analyse Shanghai Pharmaceuticals Holding Co Ltd together

PenkeI guess you are interested in Shanghai Pharmaceuticals Holding Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai Pharmaceuticals Holding Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shanghai Pharmaceuticals Holding Co Ltd

I send you an email if I find something interesting about Shanghai Pharmaceuticals Holding Co Ltd.

Quick analysis of Shanghai Pharmaceuticals Holding Co Ltd (30 sec.)










What can you expect buying and holding a share of Shanghai Pharmaceuticals Holding Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.16
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥21.64
Expected worth in 1 year
¥22.56
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥2.07
Return On Investment
12.2%

For what price can you sell your share?

Current Price per Share
¥17.05
Expected price per share
¥15.36 - ¥19.60
How sure are you?
50%

1. Valuation of Shanghai Pharmaceuticals Holding Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥17.05

Intrinsic Value Per Share

¥-15.03 - ¥-0.11

Total Value Per Share

¥6.61 - ¥21.53

2. Growth of Shanghai Pharmaceuticals Holding Co Ltd (5 min.)




Is Shanghai Pharmaceuticals Holding Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$11b$9.8b$1b9.8%

How much money is Shanghai Pharmaceuticals Holding Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$159.1m$187.6m-$28.4m-17.9%
Net Profit Margin1.8%2.4%--

How much money comes from the company's main activities?

3. Financial Health of Shanghai Pharmaceuticals Holding Co Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of Shanghai Pharmaceuticals Holding Co Ltd? (5 min.)

Welcome investor! Shanghai Pharmaceuticals Holding Co Ltd's management wants to use your money to grow the business. In return you get a share of Shanghai Pharmaceuticals Holding Co Ltd.

What can you expect buying and holding a share of Shanghai Pharmaceuticals Holding Co Ltd?

First you should know what it really means to hold a share of Shanghai Pharmaceuticals Holding Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shanghai Pharmaceuticals Holding Co Ltd is ¥17.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai Pharmaceuticals Holding Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai Pharmaceuticals Holding Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥21.64. Based on the TTM, the Book Value Change Per Share is ¥0.23 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.29 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai Pharmaceuticals Holding Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.3%0.050.3%0.060.3%0.050.3%0.050.3%
Usd Book Value Change Per Share0.040.3%0.030.2%0.010.1%0.040.2%0.040.2%
Usd Dividend Per Share0.100.6%0.040.2%0.030.2%0.030.2%0.040.2%
Usd Total Gains Per Share0.150.9%0.070.4%0.040.2%0.070.4%0.080.5%
Usd Price Per Share2.50-2.72-2.73-2.68-2.72-
Price to Earnings Ratio14.10-14.09-14.39-13.74-15.61-
Price-to-Total Gains Ratio17.02--7.03-16.50-37.17-51.65-
Price to Book Ratio0.84-0.92-0.89-0.99-1.27-
Price-to-Total Gains Ratio17.02--7.03-16.50-37.17-51.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.35972
Number of shares423
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.030.04
Usd Total Gains Per Share0.070.07
Gains per Quarter (423 shares)30.3230.04
Gains per Year (423 shares)121.29120.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
168541115665110
2136107232111129230
3203161353167194350
4271214474222258470
5339268595278323590
6407321716333388710
7474375837389452830
8542428958444517950
961048210795005821070
1067853512005556461190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%84.00.03.096.6%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%34.06.00.085.0%68.019.00.078.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%72.00.015.082.8%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%38.02.00.095.0%78.09.00.089.7%

Fundamentals of Shanghai Pharmaceuticals Holding Co Ltd

About Shanghai Pharmaceuticals Holding Co Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2024-03-27 11:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shanghai Pharmaceuticals Holding Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shanghai Pharmaceuticals Holding Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai Pharmaceuticals Holding Co Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 1.8% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 1.8%. The company is making a profit. +1
  • The TTM is 1.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%+0.0%
TTM1.8%YOY2.4%-0.6%
TTM1.8%5Y2.2%-0.4%
5Y2.2%10Y2.5%-0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%1.9%-0.1%
TTM1.8%2.2%-0.4%
YOY2.4%2.4%0.0%
5Y2.2%2.2%+0.0%
10Y2.5%2.1%+0.4%
1.1.2. Return on Assets

Shows how efficient Shanghai Pharmaceuticals Holding Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai Pharmaceuticals Holding Co Ltd to the Medical Distribution industry mean.
  • 0.6% Return on Assets means that Shanghai Pharmaceuticals Holding Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.6%+0.0%
TTM0.6%YOY0.7%-0.2%
TTM0.6%5Y0.7%-0.2%
5Y0.7%10Y0.9%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%0.8%-0.2%
TTM0.6%0.9%-0.3%
YOY0.7%0.8%-0.1%
5Y0.7%0.9%-0.2%
10Y0.9%1.0%-0.1%
1.1.3. Return on Equity

Shows how efficient Shanghai Pharmaceuticals Holding Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai Pharmaceuticals Holding Co Ltd to the Medical Distribution industry mean.
  • 1.7% Return on Equity means Shanghai Pharmaceuticals Holding Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 1.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.7%TTM1.7%+0.0%
TTM1.7%YOY2.2%-0.5%
TTM1.7%5Y2.3%-0.6%
5Y2.3%10Y2.4%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%2.1%-0.4%
TTM1.7%2.5%-0.8%
YOY2.2%2.2%0.0%
5Y2.3%2.3%+0.0%
10Y2.4%2.4%+0.0%

1.2. Operating Efficiency of Shanghai Pharmaceuticals Holding Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shanghai Pharmaceuticals Holding Co Ltd is operating .

  • Measures how much profit Shanghai Pharmaceuticals Holding Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai Pharmaceuticals Holding Co Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.9%-1.9%
TTM1.9%YOY3.5%-1.6%
TTM1.9%5Y3.3%-1.4%
5Y3.3%10Y1.8%+1.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-3.1%
TTM1.9%2.6%-0.7%
YOY3.5%3.5%+0.0%
5Y3.3%3.3%+0.0%
10Y1.8%2.0%-0.2%
1.2.2. Operating Ratio

Measures how efficient Shanghai Pharmaceuticals Holding Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.86 means that the operating costs are ¥1.86 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 1.860. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.838. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.860TTM1.838+0.022
TTM1.838YOY1.834+0.004
TTM1.8385Y1.826+0.012
5Y1.82610Y1.395+0.430
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8601.369+0.491
TTM1.8381.369+0.469
YOY1.8341.413+0.421
5Y1.8261.312+0.514
10Y1.3951.210+0.185

1.3. Liquidity of Shanghai Pharmaceuticals Holding Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shanghai Pharmaceuticals Holding Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.34 means the company has ¥1.34 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 1.345. The company is just able to pay all its short-term debts.
  • The TTM is 1.349. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.345TTM1.349-0.004
TTM1.349YOY1.365-0.016
TTM1.3495Y1.322+0.027
5Y1.32210Y0.722+0.599
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3451.366-0.021
TTM1.3491.418-0.069
YOY1.3651.403-0.038
5Y1.3221.408-0.086
10Y0.7221.299-0.577
1.3.2. Quick Ratio

Measures if Shanghai Pharmaceuticals Holding Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai Pharmaceuticals Holding Co Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.72 means the company can pay off ¥0.72 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 0.715. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.742. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.715TTM0.742-0.026
TTM0.742YOY0.762-0.020
TTM0.7425Y0.702+0.040
5Y0.70210Y0.704-0.002
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7150.758-0.043
TTM0.7420.757-0.015
YOY0.7620.828-0.066
5Y0.7020.814-0.112
10Y0.7040.850-0.146

1.4. Solvency of Shanghai Pharmaceuticals Holding Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shanghai Pharmaceuticals Holding Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai Pharmaceuticals Holding Co Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.62 means that Shanghai Pharmaceuticals Holding Co Ltd assets are financed with 62.4% credit (debt) and the remaining percentage (100% - 62.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 0.624. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.618. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.624TTM0.618+0.006
TTM0.618YOY0.608+0.010
TTM0.6185Y0.629-0.011
5Y0.62910Y0.593+0.037
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6240.617+0.007
TTM0.6180.606+0.012
YOY0.6080.6080.000
5Y0.6290.610+0.019
10Y0.5930.5930.000
1.4.2. Debt to Equity Ratio

Measures if Shanghai Pharmaceuticals Holding Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai Pharmaceuticals Holding Co Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 194.1% means that company has ¥1.94 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The MRQ is 1.941. The company is just able to pay all its debts with equity.
  • The TTM is 1.892. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.941TTM1.892+0.049
TTM1.892YOY1.818+0.074
TTM1.8925Y2.019-0.128
5Y2.01910Y1.738+0.281
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9411.698+0.243
TTM1.8921.678+0.214
YOY1.8181.752+0.066
5Y2.0191.733+0.286
10Y1.7381.7380.000

2. Market Valuation of Shanghai Pharmaceuticals Holding Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai Pharmaceuticals Holding Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shanghai Pharmaceuticals Holding Co Ltd to the Medical Distribution industry mean.
  • A PE ratio of 14.10 means the investor is paying ¥14.10 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The EOD is 13.299. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.102. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.092. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD13.299MRQ14.102-0.803
MRQ14.102TTM14.092+0.010
TTM14.092YOY14.394-0.302
TTM14.0925Y13.742+0.350
5Y13.74210Y15.608-1.866
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD13.29913.475-0.176
MRQ14.10214.623-0.521
TTM14.09218.845-4.753
YOY14.39418.249-3.855
5Y13.74217.230-3.488
10Y15.60819.682-4.074
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The EOD is -135.095. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -143.256. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -34.743. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-135.095MRQ-143.256+8.161
MRQ-143.256TTM-34.743-108.513
TTM-34.743YOY-23.407-11.336
TTM-34.7435Y-0.316-34.427
5Y-0.31610Y-50.915+50.599
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-135.0956.313-141.408
MRQ-143.2564.510-147.766
TTM-34.7437.516-42.259
YOY-23.4075.255-28.662
5Y-0.3162.484-2.800
10Y-50.9151.762-52.677
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shanghai Pharmaceuticals Holding Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.84 means the investor is paying ¥0.84 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Shanghai Pharmaceuticals Holding Co Ltd:

  • The EOD is 0.788. Based on the equity, the company is cheap. +2
  • The MRQ is 0.835. Based on the equity, the company is cheap. +2
  • The TTM is 0.919. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.788MRQ0.835-0.048
MRQ0.835TTM0.919-0.083
TTM0.919YOY0.893+0.026
TTM0.9195Y0.992-0.074
5Y0.99210Y1.274-0.281
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.7881.110-0.322
MRQ0.8351.178-0.343
TTM0.9191.224-0.305
YOY0.8931.307-0.414
5Y0.9921.386-0.394
10Y1.2742.166-0.892
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shanghai Pharmaceuticals Holding Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3240.229+42%0.070+363%0.276+17%0.285+13%
Book Value Per Share--21.64121.413+1%22.039-2%19.660+10%16.203+34%
Current Ratio--1.3451.3490%1.365-1%1.322+2%0.722+86%
Debt To Asset Ratio--0.6240.618+1%0.608+3%0.629-1%0.593+5%
Debt To Equity Ratio--1.9411.892+3%1.818+7%2.019-4%1.738+12%
Dividend Per Share--0.7390.289+155%0.224+230%0.237+211%0.274+170%
Eps--0.3210.359-11%0.405-21%0.391-18%0.340-6%
Free Cash Flow Per Share---0.0320.283-111%-0.223+606%0.171-118%0.096-133%
Free Cash Flow To Equity Per Share---0.0320.449-107%1.231-103%0.475-107%0.411-108%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.113--------
Intrinsic Value_10Y_min---15.033--------
Intrinsic Value_1Y_max--0.326--------
Intrinsic Value_1Y_min--0.007--------
Intrinsic Value_3Y_max--0.723--------
Intrinsic Value_3Y_min---1.290--------
Intrinsic Value_5Y_max--0.810--------
Intrinsic Value_5Y_min---4.013--------
Market Cap47471119590.400-41%66955683056.32072802587958.688-8%63502571497.698+5%59920216225.281+12%57698748405.177+16%
Net Profit Margin--0.0180.018+2%0.024-23%0.022-18%0.025-27%
Operating Margin---0.019-100%0.035-100%0.033-100%0.018-100%
Operating Ratio--1.8601.838+1%1.834+1%1.826+2%1.395+33%
Pb Ratio0.788-6%0.8350.919-9%0.893-6%0.992-16%1.274-34%
Pe Ratio13.299-6%14.10214.092+0%14.394-2%13.742+3%15.608-10%
Price Per Share17.050-6%18.08019.673-8%19.743-8%19.367-7%19.628-8%
Price To Free Cash Flow Ratio-135.095+6%-143.256-34.743-76%-23.407-84%-0.316-100%-50.915-64%
Price To Total Gains Ratio16.047-6%17.016-7.031+141%16.495+3%37.172-54%51.653-67%
Quick Ratio--0.7150.742-4%0.762-6%0.702+2%0.704+2%
Return On Assets--0.0060.006+1%0.007-24%0.007-23%0.009-35%
Return On Equity--0.0170.017+2%0.022-19%0.023-25%0.024-29%
Total Gains Per Share--1.0630.518+105%0.294+262%0.513+107%0.559+90%
Usd Book Value--11091878886.43710967142222.955+1%9888029641.386+12%8488504745.550+31%6705412634.984+65%
Usd Book Value Change Per Share--0.0450.032+42%0.010+363%0.038+17%0.040+13%
Usd Book Value Per Share--2.9952.964+1%3.050-2%2.721+10%2.243+34%
Usd Dividend Per Share--0.1020.040+155%0.031+230%0.033+211%0.038+170%
Usd Eps--0.0440.050-11%0.056-21%0.054-18%0.047-6%
Usd Free Cash Flow---16171476.723144948471.962-111%-80037246.012+395%75435951.548-121%39896240.606-141%
Usd Free Cash Flow Per Share---0.0040.039-111%-0.031+606%0.024-118%0.013-133%
Usd Free Cash Flow To Equity Per Share---0.0040.062-107%0.170-103%0.066-107%0.057-108%
Usd Market Cap6570002951.311-41%9266666534.99510075878173.482-8%8788755895.281+5%8292957925.579+12%7985506779.276+16%
Usd Price Per Share2.360-6%2.5022.723-8%2.732-8%2.680-7%2.716-8%
Usd Profit--164273716.393159160570.523+3%187640695.792-12%163268923.576+1%137417604.702+20%
Usd Revenue--8984396110.7658818768249.770+2%7939435941.299+13%7371679743.761+22%5718099930.680+57%
Usd Total Gains Per Share--0.1470.072+105%0.041+262%0.071+107%0.077+90%
 EOD+3 -5MRQTTM+18 -17YOY+18 -175Y+20 -1510Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Shanghai Pharmaceuticals Holding Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.299
Price to Book Ratio (EOD)Between0-10.788
Net Profit Margin (MRQ)Greater than00.018
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.715
Current Ratio (MRQ)Greater than11.345
Debt to Asset Ratio (MRQ)Less than10.624
Debt to Equity Ratio (MRQ)Less than11.941
Return on Equity (MRQ)Greater than0.150.017
Return on Assets (MRQ)Greater than0.050.006
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Shanghai Pharmaceuticals Holding Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.132
Ma 20Greater thanMa 5017.743
Ma 50Greater thanMa 10017.284
Ma 100Greater thanMa 20017.368
OpenGreater thanClose17.020
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets213,146,380
Total Liabilities133,002,747
Total Stockholder Equity68,509,810
 As reported
Total Liabilities 133,002,747
Total Stockholder Equity+ 68,509,810
Total Assets = 213,146,380

Assets

Total Assets213,146,380
Total Current Assets164,628,821
Long-term Assets48,517,560
Total Current Assets
Cash And Cash Equivalents 29,263,735
Short-term Investments 11,403,610
Net Receivables 76,158,589
Inventory 35,047,635
Other Current Assets 1,057,461
Total Current Assets  (as reported)164,628,821
Total Current Assets  (calculated)152,931,029
+/- 11,697,791
Long-term Assets
Property Plant Equipment 16,965,154
Goodwill 11,382,666
Intangible Assets 6,365,766
Long-term Assets Other 376,216
Long-term Assets  (as reported)48,517,560
Long-term Assets  (calculated)35,089,802
+/- 13,427,758

Liabilities & Shareholders' Equity

Total Current Liabilities122,429,675
Long-term Liabilities10,573,072
Total Stockholder Equity68,509,810
Total Current Liabilities
Short Long Term Debt 35,083,520
Accounts payable 58,908,747
Other Current Liabilities 6,169,225
Total Current Liabilities  (as reported)122,429,675
Total Current Liabilities  (calculated)100,161,492
+/- 22,268,183
Long-term Liabilities
Long term Debt 7,487,613
Capital Lease Obligations Min Short Term Debt1,312,972
Long-term Liabilities Other 267,500
Long-term Liabilities  (as reported)10,573,072
Long-term Liabilities  (calculated)9,068,085
+/- 1,504,986
Total Stockholder Equity
Retained Earnings 34,017,651
Total Stockholder Equity (as reported)68,509,810
Total Stockholder Equity (calculated)34,017,651
+/- 34,492,159
Other
Capital Stock3,703,301
Common Stock Shares Outstanding 3,703,301
Net Debt 13,307,398
Net Invested Capital 111,080,943
Net Working Capital 42,199,145
Property Plant and Equipment Gross 16,965,154



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
3,502,510
3,535,293
3,633,373
4,293,124
4,918,448
5,343,248
5,487,173
5,402,815
5,814,117
5,770,575
5,939,807
6,154,849
6,777,896
6,658,536
7,279,855
6,464,172
7,430,826
7,172,405
7,202,318
6,376,064
6,927,389
6,845,339
6,817,217
6,678,588
6,890,846
7,030,365
7,354,335
7,125,598
7,951,062
8,075,259
8,201,529
7,755,515
8,527,409
8,599,667
9,162,360
8,656,974
24,365,472
24,724,554
26,497,093
28,240,944
31,565,411
45,327,264
47,996,575
47,667,823
49,347,515
50,697,750
51,129,667
51,069,038
52,938,336
54,201,618
54,996,367
56,311,522
58,237,874
63,152,697
64,717,088
64,340,558
67,328,197
69,885,784
72,486,196
74,344,211
77,810,077
79,035,052
80,891,141
82,742,718
88,868,768
90,536,768
91,991,274
94,344,475
114,021,941
119,010,466
124,691,860
126,879,334
134,466,003
133,914,177
135,649,361
137,026,396
141,282,814
147,907,749
148,899,030
149,185,655
156,035,001
158,421,534
163,291,348
163,435,509
182,023,296
187,151,016
194,617,751
198,134,901
206,035,799
213,317,705
213,146,380
213,146,380213,317,705206,035,799198,134,901194,617,751187,151,016182,023,296163,435,509163,291,348158,421,534156,035,001149,185,655148,899,030147,907,749141,282,814137,026,396135,649,361133,914,177134,466,003126,879,334124,691,860119,010,466114,021,94194,344,47591,991,27490,536,76888,868,76882,742,71880,891,14179,035,05277,810,07774,344,21172,486,19669,885,78467,328,19764,340,55864,717,08863,152,69758,237,87456,311,52254,996,36754,201,61852,938,33651,069,03851,129,66750,697,75049,347,51547,667,82347,996,57545,327,26431,565,41128,240,94426,497,09324,724,55424,365,4728,656,9749,162,3608,599,6678,527,4097,755,5158,201,5298,075,2597,951,0627,125,5987,354,3357,030,3656,890,8466,678,5886,817,2176,845,3396,927,3896,376,0647,202,3187,172,4057,430,8266,464,1727,279,8556,658,5366,777,8966,154,8495,939,8075,770,5755,814,1175,402,8155,487,1735,343,2484,918,4484,293,1243,633,3733,535,2933,502,510
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
87,116,844
91,240,300
93,277,883
99,029,727
97,926,754
99,092,796
98,091,581
103,329,639
106,746,593
108,054,193
107,562,926
112,625,364
113,925,242
118,005,301
116,494,432
134,867,871
140,014,906
147,474,554
149,512,871
157,170,379
164,781,723
164,628,821
164,628,821164,781,723157,170,379149,512,871147,474,554140,014,906134,867,871116,494,432118,005,301113,925,242112,625,364107,562,926108,054,193106,746,593103,329,63998,091,58199,092,79697,926,75499,029,72793,277,88391,240,30087,116,844000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,102,772
17,113,156
18,694,669
18,529,547
18,774,720
17,229,326
18,152,818
21,718,516
25,265,866
22,221,698
22,296,233
22,106,657
22,908,222
23,061,234
22,390,386
36,631,378
26,697,397
25,491,177
27,401,396
27,040,490
31,337,367
29,263,735
29,263,73531,337,36727,040,49027,401,39625,491,17726,697,39736,631,37822,390,38623,061,23422,908,22222,106,65722,296,23322,221,69825,265,86621,718,51618,152,81817,229,32618,774,72018,529,54718,694,66917,113,15618,102,772000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
700,000
0
200,000
0
0
0
0
0
0
10,601,335
12,582,637
9,613,555
11,069,131
11,438,602
11,403,610
11,403,61011,438,60211,069,1319,613,55512,582,63710,601,335000000200,0000700,0000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
1,536,347
1,355,761
1,723,293
1,545,468
2,144,490
2,249,720
2,301,764
1,855,660
2,330,448
2,411,037
2,436,073
2,380,613
2,990,425
2,983,614
3,307,495
2,829,363
3,130,922
2,894,961
2,965,413
2,344,917
2,638,895
2,460,962
2,611,199
2,354,598
2,732,058
2,740,702
2,946,148
2,404,943
3,144,223
2,989,827
3,187,199
2,744,786
3,378,036
3,456,992
3,934,175
3,185,430
7,530,729
7,428,507
8,709,118
7,922,771
9,084,769
11,779,699
14,148,295
12,219,366
14,728,520
15,401,527
16,453,130
14,378,512
18,108,022
18,399,659
18,742,177
17,137,504
19,844,240
22,813,268
24,574,284
22,096,246
25,405,441
26,191,433
28,208,669
25,982,635
30,093,348
30,065,756
32,506,764
29,303,371
33,801,622
33,402,452
35,448,732
33,537,529
41,893,497
43,824,038
46,531,901
45,638,835
46,589,974
47,772,261
50,335,041
51,319,339
49,959,268
53,189,959
58,280,689
56,864,821
60,522,461
63,165,851
65,889,889
62,738,307
68,547,413
70,177,832
77,160,023
66,759,854
80,459,211
83,163,982
76,158,589
76,158,58983,163,98280,459,21166,759,85477,160,02370,177,83268,547,41362,738,30765,889,88963,165,85160,522,46156,864,82158,280,68953,189,95949,959,26851,319,33950,335,04147,772,26146,589,97445,638,83546,531,90143,824,03841,893,49733,537,52935,448,73233,402,45233,801,62229,303,37132,506,76430,065,75630,093,34825,982,63528,208,66926,191,43325,405,44122,096,24624,574,28422,813,26819,844,24017,137,50418,742,17718,399,65918,108,02214,378,51216,453,13015,401,52714,728,52012,219,36614,148,29511,779,6999,084,7697,922,7718,709,1187,428,5077,530,7293,185,4303,934,1753,456,9923,378,0362,744,7863,187,1992,989,8273,144,2232,404,9432,946,1482,740,7022,732,0582,354,5982,611,1992,460,9622,638,8952,344,9172,965,4132,894,9613,130,9222,829,3633,307,4952,983,6142,990,4252,380,6132,436,0732,411,0372,330,4481,855,6602,301,7642,249,7202,144,4901,545,4681,723,2931,355,7611,536,347
       Other Current Assets 
81,452
26,365
55,513
70,368
60,618
50,300
61,331
67,481
45,679
48,083
67,073
94,006
93,991
95,013
95,060
175,456
252,816
356,502
245,903
216,142
167,907
152,067
132,843
243,027
151,598
108,028
98,802
346,272
174,802
218,432
207,904
108,552
72,614
94,066
65,854
112,838
269,824
242,812
397,187
657,845
3,331,742
410,183
373,709
626,264
534,179
524,254
512,017
1,085,399
774,479
962,682
1,124,207
1,352,648
971,697
1,419,231
1,518,419
1,816,428
1,466,700
1,981,321
1,796,411
2,422,195
1,985,707
2,269,247
1,874,181
2,524,527
2,143,176
3,099,653
2,368,953
2,957,327
3,040,476
3,788,102
4,370,536
3,920,369
1,124,599
1,436,056
1,306,655
3,057,463
4,900,646
3,710,250
3,718,701
4,255,373
6,199,844
3,624,884
4,912,237
4,208,684
4,247,718
4,782,846
3,888,513
1,403,662
6,453,625
5,695,303
1,057,461
1,057,4615,695,3036,453,6251,403,6623,888,5134,782,8464,247,7184,208,6844,912,2373,624,8846,199,8444,255,3733,718,7013,710,2504,900,6463,057,4631,306,6551,436,0561,124,5993,920,3694,370,5363,788,1023,040,4762,957,3272,368,9533,099,6532,143,1762,524,5271,874,1812,269,2471,985,7072,422,1951,796,4111,981,3211,466,7001,816,4281,518,4191,419,231971,6971,352,6481,124,207962,682774,4791,085,399512,017524,254534,179626,264373,709410,1833,331,742657,845397,187242,812269,824112,83865,85494,06672,614108,552207,904218,432174,802346,27298,802108,028151,598243,027132,843152,067167,907216,142245,903356,502252,816175,45695,06095,01393,99194,00667,07348,08345,67967,48161,33150,30060,61870,36855,51326,36581,452
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,436,276
35,987,423
36,556,565
38,934,814
37,953,175
41,161,156
40,844,837
41,622,729
43,409,638
44,496,292
45,286,047
46,941,077
47,155,425
47,136,110
47,143,197
48,622,031
48,865,420
48,535,982
48,517,560
48,517,56048,535,98248,865,42048,622,03147,143,19747,136,11047,155,42546,941,07745,286,04744,496,29243,409,63841,622,72940,844,83741,161,15637,953,17538,934,81436,556,56535,987,42335,436,276000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
518,946
577,189
596,348
698,353
884,438
1,048,004
1,059,810
1,058,114
1,089,360
996,140
1,014,183
1,077,136
1,124,384
1,137,189
1,163,003
1,033,126
1,157,612
1,215,465
1,099,190
1,059,418
1,187,800
1,283,300
1,193,701
1,540,395
1,248,699
1,330,570
1,316,676
1,099,669
1,129,675
984,724
989,991
913,513
905,485
850,272
862,079
892,382
3,990,322
3,808,334
3,854,626
4,100,592
3,845,444
3,838,080
4,103,949
4,040,306
4,048,438
4,062,380
4,102,154
4,260,123
4,360,227
4,514,912
4,457,730
4,809,554
4,821,103
5,039,973
5,112,483
4,994,247
5,457,766
5,687,881
5,888,100
6,090,523
6,170,282
6,310,662
6,476,330
6,966,033
7,243,505
7,674,304
7,870,539
9,100,439
9,600,207
9,843,964
10,131,136
10,604,376
12,091,981
12,385,561
12,545,710
13,127,813
13,211,926
14,077,897
14,153,254
14,626,389
14,792,098
14,873,259
15,160,875
15,793,251
15,957,664
15,841,251
15,614,215
16,185,312
16,476,392
16,700,578
16,965,154
16,965,15416,700,57816,476,39216,185,31215,614,21515,841,25115,957,66415,793,25115,160,87514,873,25914,792,09814,626,38914,153,25414,077,89713,211,92613,127,81312,545,71012,385,56112,091,98110,604,37610,131,1369,843,9649,600,2079,100,4397,870,5397,674,3047,243,5056,966,0336,476,3306,310,6626,170,2826,090,5235,888,1005,687,8815,457,7664,994,2475,112,4835,039,9734,821,1034,809,5544,457,7304,514,9124,360,2274,260,1234,102,1544,062,3804,048,4384,040,3064,103,9493,838,0803,845,4444,100,5923,854,6263,808,3343,990,322892,382862,079850,272905,485913,513989,991984,7241,129,6751,099,6691,316,6761,330,5701,248,6991,540,3951,193,7011,283,3001,187,8001,059,4181,099,1901,215,4651,157,6121,033,1261,163,0031,137,1891,124,3841,077,1361,014,183996,1401,089,3601,058,1141,059,8101,048,004884,438698,353596,348577,189518,946
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,764
140,709
149,071
422,781
404,416
2,662,738
2,690,446
3,031,920
3,102,151
3,213,068
3,177,021
3,213,729
3,191,704
3,697,101
3,657,260
3,682,074
3,643,294
4,494,065
4,457,807
4,473,419
4,783,947
4,833,543
4,851,427
4,815,618
4,880,185
4,879,748
4,879,748
5,847,987
6,449,526
6,317,415
6,463,356
6,606,706
9,726,215
10,603,458
12,286,025
11,345,286
11,449,466
11,483,590
11,481,230
10,789,919
11,660,979
11,854,724
11,851,318
11,342,268
11,142,370
11,282,339
11,278,936
11,238,972
11,241,077
11,238,833
11,237,549
11,335,927
11,334,050
11,386,502
11,382,666
11,382,66611,386,50211,334,05011,335,92711,237,54911,238,83311,241,07711,238,97211,278,93611,282,33911,142,37011,342,26811,851,31811,854,72411,660,97910,789,91911,481,23011,483,59011,449,46611,345,28612,286,02510,603,4589,726,2156,606,7066,463,3566,317,4156,449,5265,847,9874,879,7484,879,7484,880,1854,815,6184,851,4274,833,5434,783,9474,473,4194,457,8074,494,0653,643,2943,682,0743,657,2603,697,1013,191,7043,213,7293,177,0213,213,0683,102,1513,031,9202,690,4462,662,738404,416422,781149,071140,70988,764000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,190,524
4,606,345
4,648,566
4,883,419
5,365,013
5,673,178
5,432,361
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000005,432,3615,673,1785,365,0134,883,4194,648,5664,606,3455,190,524000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
89,226
84,689
93,658
183,742
184,321
193,717
199,612
195,465
178,092
176,575
176,006
186,069
192,153
193,306
191,029
146,871
157,302
32,482
245,590
17,906
342,335
17,586
337,250
10,341
383,222
379,819
379,638
0
525,700
523,152
518,717
446,635
445,011
441,537
439,303
432,529
886,950
983,211
980,727
1,299,365
1,257,070
3,864,335
3,878,622
4,308,154
4,415,361
4,518,948
4,595,590
4,620,441
4,572,782
5,218,862
5,189,393
5,222,387
5,144,328
6,253,073
6,159,919
6,334,996
6,732,369
6,824,125
6,854,721
6,799,822
6,860,187
6,905,379
6,940,512
8,598,881
9,097,697
8,949,432
9,038,370
9,247,209
13,324,351
3,687,104
3,793,582
4,117,466
4,265,264
4,209,446
4,095,540
4,141,965
4,040,159
4,492,155
4,379,035
5,419,079
5,204,861
5,194,203
5,267,187
6,308,659
6,189,869
6,242,824
6,154,403
6,586,745
6,448,134
6,484,426
6,365,766
6,365,7666,484,4266,448,1346,586,7456,154,4036,242,8246,189,8696,308,6595,267,1875,194,2035,204,8615,419,0794,379,0354,492,1554,040,1594,141,9654,095,5404,209,4464,265,2644,117,4663,793,5823,687,10413,324,3519,247,2099,038,3708,949,4329,097,6978,598,8816,940,5126,905,3796,860,1876,799,8226,854,7216,824,1256,732,3696,334,9966,159,9196,253,0735,144,3285,222,3875,189,3935,218,8624,572,7824,620,4414,595,5904,518,9484,415,3614,308,1543,878,6223,864,3351,257,0701,299,365980,727983,211886,950432,529439,303441,537445,011446,635518,717523,152525,7000379,638379,819383,22210,341337,25017,586342,33517,906245,59032,482157,302146,871191,029193,306192,153186,069176,006176,575178,092195,465199,612193,717184,321183,74293,65884,68989,226
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
724,708
811,167
598,016
3,267,488
1,537,595
1,365,690
1,125,084
12,620,421
352,743
467,299
428,737
856,898
746,739
567,166
436,199
443,801
403,793
469,152
376,216
376,216469,152403,793443,801436,199567,166746,739856,898428,737467,299352,74312,620,4211,125,0841,365,6901,537,5953,267,488598,016811,167724,708000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
2,591,359
2,549,989
1,959,205
2,474,908
2,975,907
3,336,785
3,459,470
3,403,222
3,768,238
3,801,109
3,948,337
4,027,387
4,547,012
4,397,459
5,038,574
4,403,066
5,263,107
5,106,318
5,135,118
4,370,185
4,866,829
4,725,911
4,685,212
4,611,679
4,904,074
5,058,957
5,356,221
5,167,327
5,956,777
5,999,691
6,108,530
5,665,752
6,373,484
6,428,153
6,910,428
6,334,556
13,187,631
13,437,507
14,729,453
16,356,681
19,035,402
19,968,530
22,709,072
21,686,357
22,671,236
23,807,941
23,776,230
23,368,162
24,509,470
26,266,416
26,533,906
27,310,540
28,674,915
33,362,297
34,342,555
33,241,406
35,353,430
37,918,646
39,777,722
40,536,171
42,759,654
43,958,156
44,999,188
45,908,253
50,945,904
52,689,849
53,069,110
54,668,625
70,205,009
74,933,148
78,776,092
80,446,065
86,482,945
86,076,184
86,876,488
87,640,468
89,893,495
96,136,793
95,443,888
94,444,926
99,294,908
101,131,288
105,179,052
104,369,299
107,644,212
111,430,848
118,002,009
120,132,450
126,154,932
134,375,228
133,002,747
133,002,747134,375,228126,154,932120,132,450118,002,009111,430,848107,644,212104,369,299105,179,052101,131,28899,294,90894,444,92695,443,88896,136,79389,893,49587,640,46886,876,48886,076,18486,482,94580,446,06578,776,09274,933,14870,205,00954,668,62553,069,11052,689,84950,945,90445,908,25344,999,18843,958,15642,759,65440,536,17139,777,72237,918,64635,353,43033,241,40634,342,55533,362,29728,674,91527,310,54026,533,90626,266,41624,509,47023,368,16223,776,23023,807,94122,671,23621,686,35722,709,07219,968,53019,035,40216,356,68114,729,45313,437,50713,187,6316,334,5566,910,4286,428,1536,373,4845,665,7526,108,5305,999,6915,956,7775,167,3275,356,2215,058,9574,904,0744,611,6794,685,2124,725,9114,866,8294,370,1855,135,1185,106,3185,263,1074,403,0665,038,5744,397,4594,547,0124,027,3873,948,3373,801,1093,768,2383,403,2223,459,4703,336,7852,975,9072,474,9081,959,2052,549,9892,591,359
   > Total Current Liabilities 
2,589,023
2,559,250
1,935,438
2,413,283
2,900,668
3,269,177
3,398,256
3,332,395
3,698,183
3,726,551
3,873,789
3,894,800
4,415,125
4,265,572
4,869,239
4,272,673
5,112,415
4,974,153
4,999,103
4,243,593
4,730,009
4,572,067
4,561,261
4,587,835
4,877,270
5,017,671
5,322,766
5,126,556
5,915,915
5,957,713
6,045,207
5,581,610
6,289,072
6,361,293
6,844,323
6,258,122
12,822,875
13,121,390
14,344,283
15,942,511
18,551,942
19,371,073
21,922,114
20,855,910
21,766,782
22,839,910
22,618,318
22,098,058
23,198,376
24,801,467
24,977,474
25,698,892
27,114,600
31,704,088
32,890,786
32,002,545
34,058,222
36,578,466
38,493,079
39,426,554
39,534,718
40,806,291
41,804,697
41,113,357
46,076,055
47,668,828
48,272,441
49,631,810
67,065,843
71,619,606
73,774,947
68,709,768
73,474,128
73,982,164
74,593,505
74,607,642
76,896,815
82,706,991
81,427,401
88,132,990
92,190,256
92,332,056
93,098,773
91,824,324
95,214,624
99,940,064
107,398,441
110,691,046
114,301,936
124,339,572
122,429,675
122,429,675124,339,572114,301,936110,691,046107,398,44199,940,06495,214,62491,824,32493,098,77392,332,05692,190,25688,132,99081,427,40182,706,99176,896,81574,607,64274,593,50573,982,16473,474,12868,709,76873,774,94771,619,60667,065,84349,631,81048,272,44147,668,82846,076,05541,113,35741,804,69740,806,29139,534,71839,426,55438,493,07936,578,46634,058,22232,002,54532,890,78631,704,08827,114,60025,698,89224,977,47424,801,46723,198,37622,098,05822,618,31822,839,91021,766,78220,855,91021,922,11419,371,07318,551,94215,942,51114,344,28313,121,39012,822,8756,258,1226,844,3236,361,2936,289,0725,581,6106,045,2075,957,7135,915,9155,126,5565,322,7665,017,6714,877,2704,587,8354,561,2614,572,0674,730,0094,243,5934,999,1034,974,1535,112,4154,272,6734,869,2394,265,5724,415,1253,894,8003,873,7893,726,5513,698,1833,332,3953,398,2563,269,1772,900,6682,413,2831,935,4382,559,2502,589,023
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,077,458
2,081,951
2,691,064
21,241,544
20,808,300
20,887,451
23,138,687
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000023,138,68720,887,45120,808,30021,241,5442,691,0642,081,9512,077,458000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,077,458
2,081,951
2,691,064
21,241,544
20,808,300
20,887,451
23,138,687
25,086,963
23,508,892
20,763,331
20,139,186
21,769,160
21,772,689
22,967,427
22,514,574
27,407,275
29,000,855
29,313,886
27,750,589
32,318,083
33,724,408
35,083,520
35,083,52033,724,40832,318,08327,750,58929,313,88629,000,85527,407,27522,514,57422,967,42721,772,68921,769,16020,139,18620,763,33123,508,89225,086,96323,138,68720,887,45120,808,30021,241,5442,691,0642,081,9512,077,458000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
891,954
687,772
867,620
965,816
1,366,339
1,391,711
1,415,507
1,377,069
1,573,620
1,473,644
1,690,710
1,534,129
1,678,994
1,733,866
2,099,120
1,823,111
2,250,142
1,872,969
2,063,025
1,650,574
1,881,733
1,771,937
1,822,302
2,061,816
2,120,630
2,392,297
2,787,690
2,689,696
2,675,314
2,788,908
2,767,423
2,617,412
3,287,147
3,283,126
3,792,614
3,974,196
5,874,973
7,144,931
8,365,575
8,667,661
9,406,330
11,611,418
13,080,558
12,659,470
13,638,477
14,259,530
15,270,986
14,574,916
15,680,423
16,258,544
16,408,011
16,875,846
17,979,395
20,432,248
21,850,577
20,435,885
22,104,349
23,096,913
24,868,398
24,436,866
26,031,290
26,088,305
27,287,973
25,985,122
28,428,636
28,434,677
29,238,844
27,295,194
31,891,762
33,217,386
36,050,496
35,147,967
39,707,477
38,771,407
39,532,969
36,872,459
36,046,720
36,714,678
40,129,938
37,792,167
41,265,984
40,974,150
43,819,229
41,995,414
42,865,845
44,764,598
49,222,980
51,565,529
53,511,361
56,164,149
58,908,747
58,908,74756,164,14953,511,36151,565,52949,222,98044,764,59842,865,84541,995,41443,819,22940,974,15041,265,98437,792,16740,129,93836,714,67836,046,72036,872,45939,532,96938,771,40739,707,47735,147,96736,050,49633,217,38631,891,76227,295,19429,238,84428,434,67728,428,63625,985,12227,287,97326,088,30526,031,29024,436,86624,868,39823,096,91322,104,34920,435,88521,850,57720,432,24817,979,39516,875,84616,408,01116,258,54415,680,42314,574,91615,270,98614,259,53013,638,47712,659,47013,080,55811,611,4189,406,3308,667,6618,365,5757,144,9315,874,9733,974,1963,792,6143,283,1263,287,1472,617,4122,767,4232,788,9082,675,3142,689,6962,787,6902,392,2972,120,6302,061,8161,822,3021,771,9371,881,7331,650,5742,063,0251,872,9692,250,1421,823,1112,099,1201,733,8661,678,9941,534,1291,690,7101,473,6441,573,6201,377,0691,415,5071,391,7111,366,339965,816867,620687,772891,954
       Other Current Liabilities 
303,208
293,528
176,668
316,297
306,424
400,445
441,124
444,298
352,675
373,719
321,737
463,001
401,751
364,966
337,659
392,352
214,893
374,044
348,558
283,079
271,386
224,700
260,329
377,686
391,011
494,864
489,866
437,398
659,994
514,373
673,586
566,058
506,854
586,699
609,168
592,778
2,377,417
2,768,078
2,704,985
2,376,826
2,405,809
3,147,292
3,869,515
2,520,982
2,639,594
3,106,981
2,481,045
2,622,369
2,729,463
3,493,510
3,207,371
2,898,676
2,824,689
4,073,439
3,617,216
3,613,536
3,747,384
4,207,870
4,034,358
4,590,701
4,496,854
5,566,071
5,068,040
5,482,005
5,273,077
6,615,741
6,143,844
8,539,279
9,340,765
7,059,840
9,154,631
7,045,448
1,955,456
2,381,377
1,245,843
8,005,992
13,869,493
10,684,321
13,733,501
9,481,494
14,297,243
10,879,157
15,427,722
9,674,007
14,040,003
10,018,908
16,664,446
6,384,935
18,976,455
12,939,767
6,169,225
6,169,22512,939,76718,976,4556,384,93516,664,44610,018,90814,040,0039,674,00715,427,72210,879,15714,297,2439,481,49413,733,50110,684,32113,869,4938,005,9921,245,8432,381,3771,955,4567,045,4489,154,6317,059,8409,340,7658,539,2796,143,8446,615,7415,273,0775,482,0055,068,0405,566,0714,496,8544,590,7014,034,3584,207,8703,747,3843,613,5363,617,2164,073,4392,824,6892,898,6763,207,3713,493,5102,729,4632,622,3692,481,0453,106,9812,639,5942,520,9823,869,5153,147,2922,405,8092,376,8262,704,9852,768,0782,377,417592,778609,168586,699506,854566,058673,586514,373659,994437,398489,866494,864391,011377,686260,329224,700271,386283,079348,558374,044214,893392,352337,659364,966401,751463,001321,737373,719352,675444,298441,124400,445306,424316,297176,668293,528303,208
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,008,818
12,094,020
12,282,983
13,032,826
12,996,680
13,429,803
14,016,488
6,311,936
7,104,652
8,799,233
12,080,280
12,544,975
12,429,588
11,490,785
10,603,568
9,441,404
11,852,997
10,035,656
10,573,072
10,573,07210,035,65611,852,9979,441,40410,603,56811,490,78512,429,58812,544,97512,080,2808,799,2337,104,6526,311,93614,016,48813,429,80312,996,68013,032,82612,282,98312,094,02013,008,818000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
20,849
44,165
47,429
46,790
39,869
39,992
40,632
38,276
38,275
42,914
42,914
42,914
37,873
28,270
37,608
22,120
26,010
23,350
32,380
52,445
22,595
22,604
24,499
38,876
31,045
35,236
36,651
38,102
35,447
58,420
59,279
42,496
42,389
53,684
248,432
206,272
274,273
304,552
265,940
291,712
485,878
507,581
596,575
648,883
829,079
944,505
979,539
1,093,987
1,175,314
1,195,383
1,148,015
1,169,207
974,329
752,145
787,599
801,586
813,293
623,152
716,507
695,975
684,582
1,439,049
1,518,970
1,537,459
1,491,902
1,434,440
1,369,037
2,282,824
2,264,954
2,097,861
2,091,830
1,974,880
1,899,879
2,742,926
2,678,629
3,270,811
3,367,983
3,626,796
3,877,464
3,987,627
3,850,169
3,952,950
3,949,144
2,321,679
2,276,846
0
0
1,843,383
0
01,843,383002,276,8462,321,6793,949,1443,952,9503,850,1693,987,6273,877,4643,626,7963,367,9833,270,8112,678,6292,742,9261,899,8791,974,8802,091,8302,097,8612,264,9542,282,8241,369,0371,434,4401,491,9021,537,4591,518,9701,439,049684,582695,975716,507623,152813,293801,586787,599752,145974,3291,169,2071,148,0151,195,3831,175,3141,093,987979,539944,505829,079648,883596,575507,581485,878291,712265,940304,552274,273206,272248,43253,68442,38942,49659,27958,42035,44738,10236,65135,23631,04538,87624,49922,60422,59552,44532,38023,35026,01022,12037,60828,27037,87342,91442,91442,91438,27538,27640,63239,99239,86946,79047,42944,16520,84900
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
405,041
491,571
568,950
166,968
580,136
191,711
606,393
213,958
226,159
227,267
639,146
223,610
558,207
173,192
688,345
242,146
284,179
312,187
342,605
0
363,919
0
0363,9190342,605312,187284,179242,146688,345173,192558,207223,610639,146227,267226,159213,958606,393191,711580,136166,968568,950491,571405,041000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
724,344
794,048
1,469,723
1,505,283
1,536,913
1,575,462
1,590,701
1,559,553
1,598,094
1,648,732
1,663,954
1,729,794
1,773,276
1,818,942
1,805,589
1,763,289
1,795,135
1,815,952
1,801,116
1,757,569
1,782,597
2,119,428
1,814,338
1,755,454
1,629,686
1,614,481
1,635,532
1,641,417
1,665,682
1,684,083
1,687,997
1,689,055
1,729,505
1,728,779
1,786,951
1,833,539
8,960,733
8,996,895
9,188,393
9,134,559
9,940,450
22,727,157
22,550,612
23,078,472
23,654,900
23,772,539
24,066,067
24,639,299
25,262,937
24,916,854
25,399,989
25,953,812
26,449,508
26,561,425
27,106,099
27,822,129
28,564,488
28,490,828
29,107,049
29,930,310
30,868,010
30,818,796
31,545,608
31,622,553
32,676,204
32,547,745
33,321,182
34,030,841
37,538,029
37,387,877
38,542,763
39,013,570
40,106,222
40,085,476
40,927,774
41,659,055
42,616,426
42,919,814
44,363,939
45,354,678
47,430,186
47,715,968
48,658,776
49,359,480
64,522,215
65,329,039
66,174,933
67,063,006
68,567,458
67,358,648
68,509,810
68,509,81067,358,64868,567,45867,063,00666,174,93365,329,03964,522,21549,359,48048,658,77647,715,96847,430,18645,354,67844,363,93942,919,81442,616,42641,659,05540,927,77440,085,47640,106,22239,013,57038,542,76337,387,87737,538,02934,030,84133,321,18232,547,74532,676,20431,622,55331,545,60830,818,79630,868,01029,930,31029,107,04928,490,82828,564,48827,822,12927,106,09926,561,42526,449,50825,953,81225,399,98924,916,85425,262,93724,639,29924,066,06723,772,53923,654,90023,078,47222,550,61222,727,1579,940,4509,134,5599,188,3938,996,8958,960,7331,833,5391,786,9511,728,7791,729,5051,689,0551,687,9971,684,0831,665,6821,641,4171,635,5321,614,4811,629,6861,755,4541,814,3382,119,4281,782,5971,757,5691,801,1161,815,9521,795,1351,763,2891,805,5891,818,9421,773,2761,729,7941,663,9541,648,7321,598,0941,559,5531,590,7011,575,4621,536,9131,505,2831,469,723794,048724,344
   Common Stock
229,552
229,552
316,207
316,207
316,207
316,207
316,207
316,207
316,207
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
474,311
569,173
569,173
569,173
569,173
569,173
569,173
569,173
569,173
569,173
569,173
1,992,643
1,992,643
1,992,643
1,992,643
1,992,643
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,688,911
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
2,842,089
3,695,507
3,696,414
3,696,414
3,697,546
0
3,703,213
0
03,703,21303,697,5463,696,4143,696,4143,695,5072,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,842,0892,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9112,688,9111,992,6431,992,6431,992,6431,992,6431,992,643569,173569,173569,173569,173569,173569,173569,173569,173569,173569,173474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311474,311316,207316,207316,207316,207316,207316,207316,207229,552229,552
   Retained Earnings 
124,329
123,310
180,873
154,900
186,530
222,441
237,662
168,858
207,399
262,966
278,231
282,079
325,561
370,979
357,626
286,731
318,577
338,047
323,212
278,992
304,173
329,934
337,777
301,103
136,773
124,545
145,691
263,038
515,202
534,968
541,147
542,446
585,006
586,972
647,523
689,320
3,079,563
3,314,017
3,415,069
3,713,766
4,562,358
4,737,952
5,617,823
5,909,589
6,486,158
6,616,156
6,963,138
7,520,394
8,146,058
8,058,890
8,546,685
9,109,900
9,695,564
9,728,786
10,294,576
10,967,967
11,699,821
11,720,783
12,365,585
13,059,668
13,949,075
13,900,919
14,624,542
15,354,256
16,352,698
16,310,426
17,073,905
17,899,911
18,923,629
18,955,107
20,299,382
20,819,087
20,373,369
20,390,748
21,503,364
23,638,593
24,678,635
24,833,402
25,998,874
26,880,411
29,000,556
29,083,968
29,999,117
30,591,062
31,842,080
32,734,174
33,699,947
34,638,680
33,997,522
34,989,509
34,017,651
34,017,65134,989,50933,997,52234,638,68033,699,94732,734,17431,842,08030,591,06229,999,11729,083,96829,000,55626,880,41125,998,87424,833,40224,678,63523,638,59321,503,36420,390,74820,373,36920,819,08720,299,38218,955,10718,923,62917,899,91117,073,90516,310,42616,352,69815,354,25614,624,54213,900,91913,949,07513,059,66812,365,58511,720,78311,699,82110,967,96710,294,5769,728,7869,695,5649,109,9008,546,6858,058,8908,146,0587,520,3946,963,1386,616,1566,486,1585,909,5895,617,8234,737,9524,562,3583,713,7663,415,0693,314,0173,079,563689,320647,523586,972585,006542,446541,147534,968515,202263,038145,691124,545136,773301,103337,777329,934304,173278,992323,212338,047318,577286,731357,626370,979325,561282,079278,231262,966207,399168,858237,662222,441186,530154,900180,873123,310124,329
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-276,660
-466,050
-492,639
15,402,340
-479,409
15,093,928
-542,229
15,095,703
-624,455
15,522,976
-265,411
15,587,540
-214,649
15,817,570
-144,394
28,984,627
-306,763
28,778,572
0
0
-498,241
0
0-498,2410028,778,572-306,76328,984,627-144,39415,817,570-214,64915,587,540-265,41115,522,976-624,45515,095,703-542,22915,093,928-479,40915,402,340-492,639-466,050-276,660000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue254,877,695
Cost of Revenue-223,106,413
Gross Profit31,771,28231,771,282
 
Operating Income (+$)
Gross Profit31,771,282
Operating Expense-245,283,073
Operating Income9,594,623-213,511,791
 
Operating Expense (+$)
Research Development2,191,350
Selling General Administrative16,045,040
Selling And Marketing Expenses-
Operating Expense245,283,07318,236,389
 
Net Interest Income (+$)
Interest Income421,188
Interest Expense-1,921,583
Other Finance Cost-8,937
Net Interest Income-1,491,458
 
Pretax Income (+$)
Operating Income9,594,623
Net Interest Income-1,491,458
Other Non-Operating Income Expenses-
Income Before Tax (EBT)7,759,4469,594,623
EBIT - interestExpense = -1,921,583
4,600,016
6,521,599
Interest Expense1,921,583
Earnings Before Interest and Taxes (EBIT)-9,681,029
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax7,759,446
Tax Provision-1,797,914
Net Income From Continuing Ops5,961,5335,961,533
Net Income4,600,016
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,491,458
 

Technical Analysis of Shanghai Pharmaceuticals Holding Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai Pharmaceuticals Holding Co Ltd. The general trend of Shanghai Pharmaceuticals Holding Co Ltd is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai Pharmaceuticals Holding Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai Pharmaceuticals Holding Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 17.70 < 18.81 < 19.60.

The bearish price targets are: 16.23 > 15.36.

Tweet this
Shanghai Pharmaceuticals Holding Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai Pharmaceuticals Holding Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai Pharmaceuticals Holding Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai Pharmaceuticals Holding Co Ltd. The current macd is -0.1521903.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Pharmaceuticals Holding Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shanghai Pharmaceuticals Holding Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shanghai Pharmaceuticals Holding Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shanghai Pharmaceuticals Holding Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShanghai Pharmaceuticals Holding Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai Pharmaceuticals Holding Co Ltd. The current adx is 25.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shanghai Pharmaceuticals Holding Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Shanghai Pharmaceuticals Holding Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai Pharmaceuticals Holding Co Ltd. The current sar is 17.85.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shanghai Pharmaceuticals Holding Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai Pharmaceuticals Holding Co Ltd. The current rsi is 36.13. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Shanghai Pharmaceuticals Holding Co Ltd Daily Relative Strength Index (RSI) ChartShanghai Pharmaceuticals Holding Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai Pharmaceuticals Holding Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanghai Pharmaceuticals Holding Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shanghai Pharmaceuticals Holding Co Ltd Daily Stochastic Oscillator ChartShanghai Pharmaceuticals Holding Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai Pharmaceuticals Holding Co Ltd. The current cci is -95.68365358.

Shanghai Pharmaceuticals Holding Co Ltd Daily Commodity Channel Index (CCI) ChartShanghai Pharmaceuticals Holding Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai Pharmaceuticals Holding Co Ltd. The current cmo is -45.40695556.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shanghai Pharmaceuticals Holding Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShanghai Pharmaceuticals Holding Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai Pharmaceuticals Holding Co Ltd. The current willr is -90.90909091.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Shanghai Pharmaceuticals Holding Co Ltd Daily Williams %R ChartShanghai Pharmaceuticals Holding Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai Pharmaceuticals Holding Co Ltd.

Shanghai Pharmaceuticals Holding Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai Pharmaceuticals Holding Co Ltd. The current atr is 0.32756665.

Shanghai Pharmaceuticals Holding Co Ltd Daily Average True Range (ATR) ChartShanghai Pharmaceuticals Holding Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai Pharmaceuticals Holding Co Ltd. The current obv is -76,383,387.

Shanghai Pharmaceuticals Holding Co Ltd Daily On-Balance Volume (OBV) ChartShanghai Pharmaceuticals Holding Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai Pharmaceuticals Holding Co Ltd. The current mfi is 11.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Shanghai Pharmaceuticals Holding Co Ltd Daily Money Flow Index (MFI) ChartShanghai Pharmaceuticals Holding Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai Pharmaceuticals Holding Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Shanghai Pharmaceuticals Holding Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai Pharmaceuticals Holding Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.132
Ma 20Greater thanMa 5017.743
Ma 50Greater thanMa 10017.284
Ma 100Greater thanMa 20017.368
OpenGreater thanClose17.020
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shanghai Pharmaceuticals Holding Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shanghai Pharmaceuticals Holding Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai Pharmaceuticals Holding Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai Pharmaceuticals Holding Co Ltd

I send you an email if I find something interesting about Shanghai Pharmaceuticals Holding Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai Pharmaceuticals Holding Co Ltd.

Receive notifications about Shanghai Pharmaceuticals Holding Co Ltd in your mailbox!